JIP
AYTU icon

Jaffetilchin Investment Partners’s AYTU BioPharma AYTU Stock Holding History

Jaffetilchin Investment Partners’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,437
Closed -$32.8K – 455
2025
Q3 		$32.8K Hold
17,437
– – ﹤0.01% 436
2025
Q2 		$38K Hold
17,437
– – ﹤0.01% 426
2025
Q1 		$20.9K Buy
+17,437
New +$25.4K ﹤0.01% 402
2020
Q4 		– Sell
-72
Closed -$17K – 275
2020
Q3 		$17K Buy
72
+13
+22% +$3.34K ﹤0.01% 223
2020
Q2 		$17K Buy
+59
New +$17.9K ﹤0.01% 202

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jaffetilchin Investment Partners's AYTU Position: Q4 2025 in Review

Jaffetilchin Investment Partners sold out of AYTU BioPharma (AYTU) in Q4 2025, closing a stake of 17,437 shares — an estimated $32.8K sold.

Jaffetilchin Investment Partners first reported a position in AYTU in Q2 2020 and held it in 5 quarters. The position peaked at $38K in Q2 2025. 39 funds tracked by Wall St. Rank hold AYTU as of Q4 2025.

  • Jaffetilchin Investment Partners reported no remaining AYTU BioPharma position as of Q4 2025 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 17,437 AYTU BioPharma shares in Q4 2025, an estimated $32.8K.
  • Jaffetilchin Investment Partners first reported a position in AYTU BioPharma in Q2 2020 and held it in 5 quarters.
  • Jaffetilchin Investment Partners's AYTU BioPharma position peaked at $38K in Q2 2025.
  • 39 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2025.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2025, filed 15 Jan 2026.